Related Experiment Video
Updated: Jan 20, 2026

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells
Published on: May 2, 2017
Transferrin Modified Dioscin Loaded PEGylated Liposomes: Characterization and In Vitro Antitumor Effect
Yuanyuan Wang1, Yining Yang1, Yibin Yu1
1Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.
Abstract:
In this study, a novel transferrin modified liposomal dioscin was prepared by the film dispersion method. The transferrin modified dioscin loaded liposomes (Tf-Lip/Dio) were near-spherical in morphology and had an average particle size of 140.07±1.33 nm, a narrow polydispersity index of <0.2 and a relatively stable zeta potential of -23.7±1.16 mV. The drug entrapment efficiency (EE) and drug loading (DL) of Tf-Lip/Dio were 88.94±1.02% and 4.16±0.05%, respectively. Tf-Lip/Dio exhibited a sustained release characterization of approximately 30% of the total dioscin content after 72 h at 37 °C. Tf-Lip/Dio showed higher cytotoxic efficacy after incubation for 24 h in both HeLa cells and HepG2 cells than in nonmodified liposomes. The enhanced antitumor activity of Tf-Lip/Dio might be due to the increased intracellular uptake, which was corroborated by laser scanning confocal microscopy and flow cytometry. Furthermore, hemolysis experiments preliminarily verified the safety of its intravenous injection. Overall, this study demonstrates Tf-Lip/Dio to be a favorable delivery vehicle for dioscin in future cancer therapy.
Related Concept Videos
09:58Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells
11:31Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
14:18Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
08:53Using Scaffold Liposomes to Reconstitute Lipid-proximal Protein-protein Interactions In Vitro
The Early Endosome: Endocytosis of Transferrin
09:57Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

